These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19745170)

  • 1. Cardiovascular consequences when nitric oxide and lipid signaling converge.
    Rudolph V; Freeman BA
    Circ Res; 2009 Sep; 105(6):511-22. PubMed ID: 19745170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convergence of nitric oxide and lipid signaling: anti-inflammatory nitro-fatty acids.
    Baker PR; Schopfer FJ; O'Donnell VB; Freeman BA
    Free Radic Biol Med; 2009 Apr; 46(8):989-1003. PubMed ID: 19200454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation.
    Meurer S; Pioch S; Pabst T; Opitz N; Schmidt PM; Beckhaus T; Wagner K; Matt S; Gegenbauer K; Geschka S; Karas M; Stasch JP; Schmidt HH; Müller-Esterl W
    Circ Res; 2009 Jul; 105(1):33-41. PubMed ID: 19478201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
    Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
    J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling.
    Ignarro LJ
    Pharmacol Toxicol; 1990 Jul; 67(1):1-7. PubMed ID: 1975691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.
    Sharina IG; Sobolevsky M; Papakyriakou A; Rukoyatkina N; Spyroulias GA; Gambaryan S; Martin E
    Br J Pharmacol; 2015 May; 172(9):2316-29. PubMed ID: 25536881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of some of the biological effects of nitric oxide and its role in cell signaling.
    Murad F
    Biosci Rep; 2004; 24(4-5):452-74. PubMed ID: 16134022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive oxygen species and the control of vascular function.
    Wolin MS
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H539-49. PubMed ID: 19151250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of some of the biological effects of nitric oxide and its role in cell signaling.
    Murad F
    Biosci Rep; 1999 Jun; 19(3):133-54. PubMed ID: 10513891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic change of heme environment in soluble guanylate cyclase and complexation of NO-independent drug agents with H-NOX domain.
    Alisaraie L; Fu Y; Tuszynski JA
    Chem Biol Drug Des; 2013 Mar; 81(3):359-81. PubMed ID: 23095288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP.
    Cary SP; Winger JA; Marletta MA
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13064-9. PubMed ID: 16131543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal nitric oxide synthase and its interaction with soluble guanylate cyclase is a key factor for the vascular dysfunction of experimental sepsis.
    Nardi GM; Scheschowitsch K; Ammar D; de Oliveira SK; Arruda TB; Assreuy J
    Crit Care Med; 2014 Jun; 42(6):e391-400. PubMed ID: 24717470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
    Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
    Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and Activation of Soluble Guanylyl Cyclase, the Nitric Oxide Sensor.
    Montfort WR; Wales JA; Weichsel A
    Antioxid Redox Signal; 2017 Jan; 26(3):107-121. PubMed ID: 26979942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasomotor control in mice overexpressing human endothelial nitric oxide synthase.
    van Deel ED; Merkus D; van Haperen R; de Waard MC; de Crom R; Duncker DJ
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1144-53. PubMed ID: 17496213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme-dependent activation of guanylate cyclase by nitric oxide: a novel signal transduction mechanism.
    Ignarro LJ
    Blood Vessels; 1991; 28(1-3):67-73. PubMed ID: 1672101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox Mechanisms Influencing cGMP Signaling in Pulmonary Vascular Physiology and Pathophysiology.
    Patel D; Lakhkar A; Wolin MS
    Adv Exp Med Biol; 2017; 967():227-240. PubMed ID: 29047089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F; Waldman S; Molina C; Bennett B; Leitman D
    Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiol oxidation inhibits nitric oxide-mediated pulmonary artery relaxation and guanylate cyclase stimulation.
    Mingone CJ; Gupte SA; Ali N; Oeckler RA; Wolin MS
    Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L549-57. PubMed ID: 16272175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.